These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34310468)

  • 1. Genetic Study of Fanconi Anemia in Infancy Revealed FANCI Mutations and Defective ALDH2 Variant: A Case Report.
    Urata T; Imamura T; Osone S; Muramatsu H; Takahashi Y; Hosoi H
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e438-e441. PubMed ID: 34310468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
    Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
    Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies.
    Nie D; Zhang J; Wang F; Zhang W; Liu L; Chen X; Zhang Y; Cao P; Xiong M; Wang T; Wu P; Ma X; Tian W; Wang M; Chen KN; Liu H
    BMC Med Genet; 2020 Jun; 21(1):118. PubMed ID: 32487094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients.
    Hira A; Yabe H; Yoshida K; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Nakamura J; Kojima S; Ogawa S; Matsuo K; Takata M; Yabe M
    Blood; 2013 Oct; 122(18):3206-9. PubMed ID: 24037726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenotype and clinical course of Japanese Fanconi Anaemia infants is influenced by patient, but not maternal ALDH2 genotype.
    Yabe M; Yabe H; Morimoto T; Fukumura A; Ohtsubo K; Koike T; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Hira A; Takata M
    Br J Haematol; 2016 Nov; 175(3):457-461. PubMed ID: 27377053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel FANCI mutations in Fanconi anemia with VACTERL association.
    Savage SA; Ballew BJ; Giri N; ; Chandrasekharappa SC; Ameziane N; de Winter J; Alter BP;
    Am J Med Genet A; 2016 Feb; 170A(2):386-391. PubMed ID: 26590883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects.
    George M; Solanki A; Chavan N; Rajendran A; Raj R; Mohan S; Nemani S; Kanvinde S; Munirathnam D; Rao S; Radhakrishnan N; Lashkari HP; Ghildhiyal RG; Manglani M; Shanmukhaiah C; Bhat S; Ramesh S; Cherian A; Junagade P; Vundinti BR
    Hum Mutat; 2021 Dec; 42(12):1648-1665. PubMed ID: 34585473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new Fanconi anemia-like disorder, aldehyde degradation deficiency syndrome: two defense mechanisms working together for the genome and hematopoiesis].
    Takata M
    Rinsho Ketsueki; 2023; 64(7):639-645. PubMed ID: 37544724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair.
    Colnaghi L; Jones MJ; Cotto-Rios XM; Schindler D; Hanenberg H; Huang TT
    Blood; 2011 Feb; 117(7):2247-56. PubMed ID: 20971953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
    Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
    Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.
    Mu A; Hira A; Niwa A; Osawa M; Yoshida K; Mori M; Okamoto Y; Inoue K; Kondo K; Kanemaki MT; Matsuda T; Ito E; Kojima S; Nakahata T; Ogawa S; Tanaka K; Matsuo K; Saito MK; Takata M
    Blood; 2021 Apr; 137(15):2021-2032. PubMed ID: 33512438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALDH2 mutations and defense against genotoxic aldehydes in cancer and inherited bone marrow failure syndromes.
    Woo AY; Jia L
    Mutat Res; 2024; 829():111870. PubMed ID: 38944932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway.
    Sims AE; Spiteri E; Sims RJ; Arita AG; Lach FP; Landers T; Wurm M; Freund M; Neveling K; Hanenberg H; Auerbach AD; Huang TT
    Nat Struct Mol Biol; 2007 Jun; 14(6):564-7. PubMed ID: 17460694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells.
    Van Wassenhove LD; Mochly-Rosen D; Weinberg KI
    Mol Genet Metab; 2016 Sep; 119(1-2):28-36. PubMed ID: 27650066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acquired BMF with FANCL gene heterozygous mutation: Case report.
    Zhang N; Wang X; Miao XJ; Zhang XP; Xia XY; Li L; Sun HP
    Medicine (Baltimore); 2023 Jun; 102(24):e34036. PubMed ID: 37327301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis.
    Gueiderikh A; Maczkowiak-Chartois F; Rosselli F
    Blood Rev; 2022 Mar; 52():100904. PubMed ID: 34750031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
    Boisvert RA; Howlett NG
    Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FANCA and FANCG are the major Fanconi anemia genes in the Korean population.
    Park J; Chung NG; Chae H; Kim M; Lee S; Kim Y; Lee JW; Cho B; Jeong DC; Park IY
    Clin Genet; 2013 Sep; 84(3):271-5. PubMed ID: 23067021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.